MAPKAPK5-AS1/miR-515-5p/CAB39 Axis Contributes to Non-small Cell Lung Cancer Cell Proliferation and Migration
-
Published:2023-03-03
Issue:11
Volume:65
Page:1887-1897
-
ISSN:1073-6085
-
Container-title:Molecular Biotechnology
-
language:en
-
Short-container-title:Mol Biotechnol
Author:
Zhao Yueming, Zhou Danyang, Yuan Yuan, Chen Yubao, Zhang Kai, Tan YanORCID, Fang Surong
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,Bioengineering,Biotechnology
Reference32 articles.
1. Poston, G. J. (2015). Global cancer surgery: The lancet oncology review. European Journal of Surgical Oncology, 41, 1559–1561. 2. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424. 3. Cooper, W. A., Lam, D. C., O’Toole, S. A., & Minna, J. D. (2013). Molecular biology of lung cancer. Journal of Thoracic Disease, 5(Suppl 5), S479-490. 4. Ettinger, D. S., Akerley, W., Bepler, G., Blum, M. G., Chang, A., Cheney, R. T., Chirieac, L. R., D’Amico, T. A., Demmy, T. L., Ganti, A. K., Govindan, R., Grannis, F. W., Jr., Jahan, T., Jahanzeb, M., Johnson, D. H., Kessinger, A., Komaki, R., Kong, F. M., Kris, M. G., … Yang, S. C. (2010). Non-small cell lung cancer. Journal of the National Comprehensive Cancer Network: JNCCN, 8, 740–801. 5. Zhou, Y. Y., Hu, Z. G., Zeng, F. J., & Han, J. (2016). Clinical profile of cyclooxygenase-2 inhibitors in treating non-small cell lung cancer: A meta-analysis of nine randomized clinical trials. PLoS ONE, 11, e0151939.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|